Trials / Completed
CompletedNCT01534780
3 Fixation Devices in Laparoscopic Ventral Herniotomy
A Controlled Randomized Study of Protack, Securestrap and Glubran Glue as Fixation Devices in Laparoscopic Ventral Herniotomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Horsens Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Clinical, controlled, randomized, prospective study. Ventral hernias between 2(1.5)cm and 7 cm, laparoscopic surgery with intraperitoneal onlay mesh. Three randomization groups of 25 patients giving a total of 75 patients. Mesh is fixated with either Protack, Securestrap or Glubran II. Primary outcome: postoperative pain on the 2nd postoperative day. Secondary outcomes: pain, quality of life, recurrence and adhesions at 1, 6, 12, 24, 36, 48 and 60 months postoperative.
Detailed description
see brief summary
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | laparoscopic ventral herniotomy | Laparoscopy in general anesthesia are performed with placement of Physiomesh intraperitoneally. Fixation of the mesh is performed with 1 of 3 possible devices |
| DEVICE | Protack | fixation of mesh with protack |
| DEVICE | Securestrap | fixation of mesh with Securestrap |
| DEVICE | Glubran | fixation of mesh with Glubran |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2012-02-17
- Last updated
- 2020-02-19
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01534780. Inclusion in this directory is not an endorsement.